The challenges of classical swine fever control: Modified live and E2 subunit vaccines

Virus Research

Volumn 179, Issue 1, 2014, Pages 1-11

  Huang, Yu Liang ^a   Deng, Ming Chung ^a   Wang, Fun In ^b   Huang, Chin Cheng ^a   Chang, Chia Yi ^a  

^a FISHERIES RESEARCH INSTITUTE   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Classical swine fever virus; E2 glycoprotein; E2 subunit vaccine; Modified live vaccine

Indexed keywords

E2 SUBUNIT VACCINE; GLYCOPROTEIN E2; LIVE VACCINE; MARKER VACCINE; MATERNAL ANTIBODY; SUBUNIT VACCINE; UNCLASSIFIED DRUG;

ANTIGENIC VARIATION; CEREBROSPINAL FLUID; CLASSICAL SWINE FEVER; DOMESTIC PIG; DRUG EFFICACY; EPIDEMIC; GENOTYPE; HUMAN; IMMUNE RESPONSE; NATURAL HOST; NONHUMAN; PRIORITY JOURNAL; PROPHYLAXIS; REVIEW; SOW (SWINE); VACCINATION; VIRUS LOAD; WILD BOAR;

ANIMALIA; CLASSICAL SWINE FEVER VIRUS; SUIDAE; SUS SCROFA; SUS SCROFA DOMESTICA;

CLASSICAL SWINE FEVER VIRUS; E2 GLYCOPROTEIN; E2 SUBUNIT VACCINE; MODIFIED LIVE VACCINE;

ANIMALS; ANTIBODIES, VIRAL; CLASSICAL SWINE FEVER; CLASSICAL SWINE FEVER VIRUS; SWINE; VACCINES, SUBUNIT; VIRAL VACCINES;

EID: 84892827826     PISSN: 01681702     EISSN: 18727492     Source Type: Journal    
DOI: 10.1016/j.virusres.2013.10.025     Document Type: Review

References (131)

1. Ahrens U., Kaden V., Drexler C., Visser N. Efficacy of the classical swine fever (CSF) marker vaccine Porcilis Pesti in pregnant sows. Vet. Microbiol. 2000, 77:83-97.
2. Armengol E., Wiesmuller K.H., Wienhold D., Buttner M., Pfaff E., Jung G., Saalmuller A. Identification of T-cell epitopes in the structural and non-structural proteins of classical swine fever virus. J. Gen. Virol. 2002, 3:551-560.
3. Beer M., Reimann I., Hoffmann B., Depner K. Novel marker vaccines against classical swine fever. Vaccine 2007, 25:5665-5670.
4. Belak K., Koenen F., Vanderhallen H., Mittelholzer C., Feliziani F., De Mia G.M., Belak S. Comparative studies on the pathogenicity and tissue distribution of three virulence variants of classical swine fever virus, two field isolates and one vaccine strain, with special regard to immunohistochemical investigations. Acta Vet. Scand. 2008, 50:34.
5. Bensaude E., Turner J.L., Wakeley P.R., Sweetman D.A., Pardieu C., Drew T.W., Wileman T., Powell P.P. Classical swine fever virus induces proinflammatory cytokines and tissue factor expression and inhibits apoptosis and interferon synthesis during the establishment of long-term infection of porcine vascular endothelial cells. J. Gen. Virol. 2004, 85:1029-1037.
6. Blome S., Aebischer A., Lange E., Hofmann M., Leifer I., Loeffen W., Koenen F., Beer M. Comparative evaluation of live marker vaccine candidates CP7_E2alf and flc11 along with C-strain Riems after oral vaccination. Vet. Microbiol. 2012, 158:42-59.
7. Blome S., Meindl-Bohmer A., Loeffen W., Thuer B., Moennig V. Assessment of classical swine fever diagnostics and vaccine performance. Rev. Sci. Tech. Off. Int. Epiz. 2006, 25:1025-1038.
8. Bouma A., de Smit A.J., de Jong M.C.M., de Kluijver E.P., Moormann R.J.M. Determination of the onset of the herd-immunity induced by the E2 sub-unit vaccine against classical swine fever virus. Vaccine 2000, 18:1374-1381.
9. Bouma A., de Smit A.J., de Kluijver E.P., Terpstra C., Moormann R.J.M. Efficacy and stability of a subunit vaccine based on glycoprotein E2 of classical swine fever virus. Vet. Microbiol. 1999, 66:101-114.
10. rns of pestivirus induces apoptosis in lymphocytes of several species. J. Virol. 1997, 71:6692-6696.
11. Ceppi M., de Bruin M.G.M., Seuberlich T., Balmelli C., Pascolo S., Ruggli N., Wienhold D., Tratschin J.D., McCullough K.C., Summerfield A. Identification of classical swine fever virus protein E2 as a target for cytotoxic T cells by using mRNA-transfected antigen-presenting cells. J. Gen. Virol. 2005, 86:2525-2534.
12. Cha S.H., Choi E.J., Park J.H., Yoon S.R., Kwon J.H., Yoon K.J., Song J.Y. Phylogenetic characterization of classical swine fever viruses isolated in Korea between 1988 and 2003. Virus Res. 2007, 126:256-261.
13. Chang C.Y., Huang C.C., Deng M.C., Huang Y.L., Lin Y.J., Liu H.M., Lin Y.L., Wang F.I. Antigenic mimicking with cysteine-based cyclized peptides reveals a previously unknown antigenic determinant on E2 glycoprotein of classical swine fever virus. Virus Res. 2012, 163:190-196.
14. Chang C.Y., Huang C.C., Deng M.C., Huang Y.L., Lin Y.J., Liu H.M., Lin Y.L., Wang F.I. Identification of conformational epitopes and antigen-specific residues at the D/A domains and the extramembrane C-terminal region of E2 glycoprotein of classical swine fever virus. Virus Res. 2012, 168:56-63.
15. Chang C.Y., Huang C.C., Lin Y.J., Deng M.C., Chen H.C., Tsai C.H., Chang W.M., Wang F.I. Antigenic domains analysis of classical swine fever virus E2 glycoprotein by mutagenesis and conformation-dependent monoclonal antibodies. Virus Res. 2010, 149:183-189.
16. Chang C.Y., Huang C.C., Lin Y.J., Deng M.C., Tsai C.H., Chang W.M., Wang F.I. Identification of antigen-specific residues on E2 glycoprotein of classical swine fever virus. Virus Res. 2010, 152:65-72.
17. Chen N., Hu H., Zhang Z., Shuai J., Jiang L., Fang W. Genetic diversity of the envelope glycoprotein E2 of classical swine fever virus: recent isolates branched away from historical and vaccine strains. Vet. Microbiol. 2008, 127:286-299.
18. Chen N., Tong C., Li D., Wan J., Yuan X., Li X., Peng J., Fang W. Antigenic analysis of classical swine fever virus E2 glycoprotein using pig antibodies identifies residues contributing to antigenic variation of the vaccine C-strain and group 2 strains circulating in China. Virol. J. 2010, 7:378.
19. Chenut G., Saintilan A.-F., Burger C., Rosenthal F., Cuciere C., Picard M., Bruyere V., Albina E. Oral immunisation of swine with a classical swine fever vaccine (C-strain) and transmission studies in rabbits and sheep. Vet. Microbiol. 1999, 64:265-276.
20. Chinsakchai S., Molitor T.W. Immunobiology of pseudorabies virus infection in swine. Vet. Immunol. Immunopathol. 1994, 43:107-116.
21. Choi C., Hwang K.K., Chae C. Classical swine fever virus induces tumor necrosis factor-α and lymphocyte apoptosis. Arch. Virol. 2004, 149:875-889.
22. Darwich L., Segales J., Mateu E. Pathogenesis of postweaning multisystemic wasting syndrome caused by porcine circovirus 2: an immune riddle. Arch. Virol. 2004, 149:857-874.
23. de Smit A.J., Bouma A., de Kluijver E.P., Terpstra C., Moormann R.J.M. Prevention of transplacental transmission of moderate-virulent classical swine fever virus after single or double vaccination with an E2 subunit vaccine. Vet. Q. 2000, 22:150-153.
24. de Smit A.J., Bouma A., de Kluijver E.P., Terpstra C., Moormann R.J.M. Duration of the protection of an E2 subunit marker vaccine against classical swine fever after a single vaccination. Vet. Microbiol. 2001, 78:307-317.
25. Deng M.C., Huang C.C., Huang T.S., Chang C.Y., Lin Y.J., Chien M.S., Jong M.H. Phylogenetic analysis of classical swine fever virus isolated from Taiwan. Vet. Microbiol. 2005, 106:187-193.
26. Depner K.R., Bouma A., Koenen F., Klinkenberg D., Lange E., de Smit H., Vanderhallen H. Classical swine fever (CSF) marker vaccine-Trial II, Challenge study in pregnant sows. Vet. Microbiol. 2001, 83:107-120.
27. Dewulf J., Laevens H., Koenen F., Mintiens K., de Kruif A. An E2 sub-unit marker vaccine does not prevent horizontal or vertical transmission of classical swine fever virus. Vaccine 2002, 20:86-91.
28. Dewulf J., Laevens H., Koenen F., Mintiens K., de Kruif A. Efficacy of E2-sub-unit marker and C-strain vaccines in reducing horizontal transmission of classical swine fever virus in weaner pigs. Prev. Vet. Med. 2004, 65:121-133.
29. Dewulf J., Laevens H., Koenen F., Vanderhallen H., Mintiens K., Deluyker H., de Kruif A. An experimental infection with classical swine fever in E2 subunit marker-vaccine vaccinated and in non-vaccinated pigs. Vaccine 2001, 19:475-482.
30. Dong X.N., Qi Y., Ying J., Chen X., Chen Y.H. Candidate peptide-vaccine induced potent protection against CSFV and identified a principal sequential neutralizing determinant on E2. Vaccine 2006, 24:426-434.
31. Everett H., Crooke H., Gurrala R., Dwarka R., Kim J., Botha B., Lubisi A., Pardini A., Gers S., Vosloo W., Drew T. Experimental infection of common warthogs (Phacochoerus africanus) and Bushpigs (Potamochoerus larvatus) with Classical Swine Fever Virus. I: Susceptibility and transmission. Transbound Emerg. Dis. 2011, 58:128-134.
32. Floegel-Niesmann G. Classical swine fever (CSF) marker vaccine-Trial III. Evaluation of discriminatory ELISAs. Vet. Microbiol. 2001, 83:121-136.
33. Franzoni G., Kurkure N.V., Edgar D., Everett H.E., Gerner W., Bodman-Smith K.B., Crooke H.R., Graham S.P. Assessment of the phenotype and functionality of porcine CD8T cell responses following vaccination with live attenuated classical swine fever virus and virulent virus challenge. Clin. Vaccine Immunol. 2013, [Epub ahead of print]. 10.1128/CVI.00415-13.
34. Ganges L., Barrera M., Nunez J.I., Blanco I., Frias M.T., Rodriguez F., Sobrino F. A DNA vaccine expressing the E2 protein of classical swine fever virus elicits T cell responses that can prime for rapid antibody production and confer total protection upon viral challenge. Vaccine 2005, 23:3741-3752.
35. Ganges L., Nunez J.I., Sobrino F., Borrego B., Fernandez-Borges N., Frias-Lepoureau M.T., Rodriguez F. Recent advances in the development of recombinant vaccines against classical swine fever virus: cellular responses also play a role in protection. Vet. J. 2008, 177:169-177.
36. Gers S., Vosloo W., Drew T., Lubisi A.B., Pardini A., Williams M. Experimental infection of common warthogs (Phacochoerus africanus) and Bushpigs (Potamochoerus larvatus) with classical swine fever virus II: A comparative histopathological study. Transbound. Emerg. Dis. 2011, 58:135-144.
37. Graham S.P., Everett H.E., Haines F.J., Johns H.L., Sosan O.A., Salguero F.J., Clifford D.J., Steinbach F., Drew T.W., Crooke H.R. Challenge of pigs with classical swine fever viruses after C-strain vaccination reveals remarkably rapid protection and insights into early immunity. PLoS ONE 2012, 7:e29310.
38. Graham S.P., Haines F.J., Johns H.L., Sosan O., La Rocca S.A., Lamp B., Rumenapf T., Everett H.E., Crooke H.R. Characterisation of vaccine-induced, broadly cross-reactive IFN-γ secreting T cell responses that correlate with rapid protection against classical swine fever virus. Vaccine 2012, 30:2742-2748.
39. Greiser-Wilke I., Fritzemeier J., Koenen F., Vanderhallen H., Rutili D., De Mia G.M., Romero L., Rosell R., Sanchez-Vizcaino J.M., San Gabriel A. Molecular epidemiology of a large classical swine fever epidemic in the European Union in 1997-1998. Vet. Microbiol. 2000, 77:17-27.
40. Huang Y.L., Pang V.F., Deng M.C., Chang C.Y., Shih C.N., Wan C.H., Jeng C.R. Reduction of classical swine fever virus-specific cell proliferative response of porcine peripheral blood mononuclear cells by porcine circovirus type 2. Taiwan Vet. J. 2012, 38:164-176.
41. Huang Y.L., Pang V.F., Lin C.M., Tsai Y.C., Chia M.Y., Deng M.C., Chang C.Y., Jeng C.R. Porcine circovirus type 2 (PCV2) infection decreases the efficacy of an attenuated classical swine fever virus (CSFV) vaccine. Vet. Res. 2011, 42:115.
42. rns. J. Virol. 2000, 74:9553-9561.
43. Hulst M.M., Westra D.F., Wensvoort G., Moormann R.J. Glycoprotein E1 of hog cholera virus expressed in insect cells protects swine from hog cholera. J. Virol. 1993, 67:5435-5442.
44. Ishikawa k, Nagai H., Katayama K., Tsutsui M., Tanabayashi K., Takeuchi K., Hishiyama M., Saitoh A., Takagi M., Gotoh K., Maramatsu M., Yamada A. Comparison of the entire nucleotide and deduced amino acid sequences of the attenuated hog cholera vaccine strain GPE- and the wild-type parental strain ALD. Arch. Virol. 1995, 140:1385-1391.
45. Jong M.H., Chan I.P., Chi C.W., Huang C.C., Chiou T.F., Lee J.T., Hung W.K. Immunoprotection induced by tissue culture-adapted LPC strain of hog cholera virus. Exp. Rep. Taiwan Provincial Res. Inst. Animal Heath. 1989, 25:49-58.
46. Jong M.H., Huang C.C., Chan I.P., Liu T.H., Chi C.W., Chiou T.F., Lee J.T. Development of tissue culture hog cholera vaccine. Exp. Rep. Taiwan Provincial Res. Inst. Animal Heath. 1988, 24:33-41.
47. Kaden V., Lange B. Oral immunization against classical swine fever (CSF): onset and duration of immunity. Vet. Microbiol. 2001, 82:301-310.
48. King A.M.Q., Adams M.J., Carstens E.B., Lefkowitz E.J. Virus Taxonomy: Ninth Report of the International Committee on Taxonomy of Viruses 2011, Elsevier Academic Press, San Diego, USA.
49. Klinkenberg D., Moormann R.J.M., de Smit A.J., Bouma A., de Jong M.C.M. Influence of maternal antibodies on efficacy of a subunit vaccine: transmission of classical swine fever virus between pigs vaccinated at 2 weeks of age. Vaccine 2002, 20:3005-3013.
50. Koenig P., Hoffmann B., Depner K.R., Reimann I., Teifke J.P., Beer M. Detection of classical swine fever vaccine virus in blood and tissue samples of pigs vaccinated either with a conventional C-strain vaccine or a modified live marker vaccine. Vet. Microbiol. 2007, 120:343-351.
51. König M., Lengsfeld T., Pauly T., Stark R., Thiel H.-J. Classical swine fever virus: independent induction of protective immunity by two structural glycoproteins. J. Virol. 1995, 69:6479-6486.
52. Kortekaas J., Vloet R.P.M., Weerdmeester K., Ketelaar J., van Eijk M., Loeffen W.L. Rational design of a classical swine fever C-strain vaccine virus that enables the differentiation between infected and vaccinated animals. J. Virol. Methods 2010, 163:175-185.
53. Kosmidou A., Ahl R., Thiel H.-J., Weiland E. Differentiation of classical swine fever virus (CSFV) strains using monoclonal antibodies against structural glycoproteins. Vet. Microbiol. 1995, 47:111-118.
54. rns for serologic diagnosis of pestivirus infections in swine. J. Clin. Microbiol. 2001, 39:906-912.
55. Launais M., Aynaud J.M., Corthier G. Peste porcine classique: proprieties d'un clone (soucje Thiverval) isoleen culture celluliare a basse temperature. Applivation dans la vaccination. Rev. Med. Vet. 1972, 123:1537-1554.
56. Lee W.C., Wang C.S., Chien M.S. Virus antigen expression and alterations in peripheral blood mononuclear cell subpopulations after classical fever virus infection. Vet. Microbiol. 1999, 67:17-29.
57. Li G.X., Zhou Y.J., Yu H., Li L., Wang Y.X., Tong W., Hou J.W., Xu Y.Z., Zhu J.P., Xu A.T., Tong G.Z. A novel dendrimeric peptide induces high level neutralizing antibodies against classical swine fever virus in rabbits. Vet. Microbiol. 2012, 156:200-204.
58. Lin M., Lin F., Mallory M., Clavijo A. Deletions of structural glycoprotein E2 of classical swine fever virus strain Alfort/187 resolve a linear epitope of monoclonal antibody WH303 and the minimal N-terminal domain essential for binding immunoglobulin G antibodies of a pig hyperimmune serum. J. Virol. 2000, 74:11619-11625.
59. Lin T.T.C., Lee R.C.T. An overall report on the development of a highly safe and potent lapinized hog cholera virus strain for hog cholera control in Taiwan. Natl. Sci. Coun. Spec. Publ. 1981, 5:1-44.
60. Lindenbach B.D., Thiel H.-J., Rice C.M. Flaviviridae: the viruses and their replication. Fields Virology 2007, 1101-1152. Lippincott Williams & Wilkins, Philadelphia, PA. 5th ed. D.M. Knipe, P.M. Howley, D.E. Griffin (Eds.).
61. Lipowski A., Drexler C., Pejsak Z. Safety and efficacy of a classical swine fever subunit vaccine in pregnant sows and their offspring. Vet. Microbiol. 2000, 77:99-108.
62. Liu J., Fan X.Z., Wang Q., Xu L., Zhao Q.Z., Huang W., Zhou Y.C., Tang B., Chen L., Zou X.Q., Sha S., Zhu Y.Y. Dynamic distribution and tissue tropism of classical swine fever virus in experimentally infected pigs. Virol. J. 2011, 8:201.
63. Liu S., Tu C., Wang C., Yu X., Wu J., Guo S., Shao M., Gong Q., Zhu Q., Kong X. The protective immune response induced by B cell epitope of classical swine fever virus glycoprotein E2. J. Virol. Methods 2006, 134:125-129.
64. Liu S., Yu X., Wang C., Wu J., Kong X., Tu C. Quadruple antigenic epitope peptide producing immune protection against classical swine fever virus. Vaccine 2006, 24:7175-7180.
65. Luo L., Nishi K., Macleod E., Sabara M.I., Lin M., Handel K., Pasick J. Baculovirus expression and antigenic characterization of classical swine fever virus E2 proteins. Transbound. Emerg. Dis. 2013, 60:143-151.
66. Mateu E., Diaz I. The challenge of PRRS immunology. Vet. J. 2008, 177:345-351.
67. Mendoza S., Correa-Giron P., Aguilera E., Colmenares G., Torres O., Cruz T., Romero A., Hernandez-Baumgarten E., Ciprián A. Antigenic differentiation of classical swine fever vaccinal strain PAV-250 from other strains, including field strains from Mexico. Vaccine 2007, 25:7120-7124.
68. Monsó M., Tarradas J., de la Torre B.G., Sobrino F., Ganges L., Andreu D. Peptide vaccine candidates against classical swine fever virus: T cell and neutralizing antibody responses of dendrimers displaying E2 and NS2-3 epitopes. J. Pept. Sci. 2011, 17:24-31.
69. Moormann R.J.M., Bouma A., Kramps J.A., Terpstra C., de Smit H.J. Development of a classical swine fever subunit marker vaccine and companion diagnostic test. Vet. Microbiol. 2000, 73:209-219.
70. Nishimori T., Yamada S., Shimizu M. Production of monoclonal antibodies against classical swine fever virus and their use for antigenic characterization of Japanese isolates. J. Vet. Med. Sci. 1996, 58:707-710.
71. Oleksiewicz M.B., Rasmussen T.B., Normann P., Uttenthal Å. Determination of the sequence of the complete open reading frame and the 5'NTR of the Paderborn isolate of classical swine fever virus. Vet. Microbiol. 2003, 92:311-325.
72. Ophuis R.J., Morrissy C.J., Boyle D.B. Detection and quantitative pathogenesis study of classical swine fever virus using a real time RT-PCR assay. J. Virol. Methods 2006, 131:78-85.
73. Ozawa Y., Makino S., Park J.Y., Chang J.H., Kim J.H., An S.H. A review of recent unexpected animal disease events in Japan and Korea and the follow-up action taken. Rev. Sci. Tech. Off. Int. Epiz. 2006, 25:125-135.
74. Pan C.H., Jong M.H., Huang Y.L., Huang T.S., Chao P.H., Lai S.S. Rapid detection and differentiation of wild-type and three attenuated lapinized vaccine strains of Classical swine fever virus by reverse transcription polymerase chain reaction. J. Vet. Diagn. Invest. 2008, 20:448-456.
75. Parchariyanon S., Tantaswasdi U., Pinyochon W., Methiyapun P. Immunity against swine fever vaccine, II. Immunity against swine fever vaccine in piglets and protection level of maternal immunity in piglets before vaccination. J. Thai. Vet. Med. Assoc. 1994, 45:37-45.
76. Paton D.J., McGoldrick A., Greiser-Wilke I., Parchariyanon S., Song J.Y., Liou P.P., Stadejek T., Lowings J.P., Björklund H., Belák S. Genetic typing of classical swine fever virus. Vet. Microbiol. 2000, 73:137-157.
77. Pauly T., Elbers K., Konig M., Lengsfeld T., Saalmuller A., Theil H.J. Classical swine fever virus-specific cytotoxic T lymphocytes and identification of a T cell epitope. J. Gen. Virol. 1995, 76:3039-3049.
78. Pauly T., Konig M., Thie H.J., Saalmuller A. Infection with classical swine fever virus: effects on phenotype and immune responsiveness of porcine T lymphocytes. J. Gen. Virol. 1998, 79:31-40.
79. Peeters B., Bienkowska-Szewczyk K., Hulst M., Gielkens A., Kimman T. Biologically safe, non-transmissible pseudorabies virus vector vaccine protects pigs against both Aujeszky's disease and classical swine fever. J. Gen. Virol. 1997, 78:3311-3315.
80. Peng W.P., Hou Q., Xia Z.H., Chen D., Li N., Sun Y., Qiu H.J. Identification of a conserved linear B-cell epitope at the N-terminus of the E2 glycoprotein of classical swine fever virus by phage-displayed random peptide library. Virus Res. 2008, 135:267-272.
81. Piriou L., Chevallier S., Hutet E., Charley B., Le Potier M.F., Albina E. Humoral and cell-mediated immune responses of d/d histocompatible pigs against classical swine fever (CSF) virus. Vet. Res. 2003, 34:389-404.
82. Qi Y., Zhang B.Q., Shen Z., Chen Y.H. Antigens containing TAVSPTTLR tandem repeats could be used in assaying antibodies to classical swine fever virus. Acta Virol. 2009, 53:241-246.
83. Rasmussen T.B., Uttenthal Å., Reimann I., Nielsen J., Depner K., Beer M. Virulence, immunogenicity and vaccine properties of a novel chimeric pestivirus. J. Gen. Virol. 2007, 88:481-486.
84. Rau H., Revets H., Balmelli C., McCullough K.C., Summerfield A. Immunological properties of recombinant classical swine fever virus NS3 protein in vitro and in vivo. Vet. Res. 2006, 37:155-168.
85. Reimann I., Depner K., Utke K., Leifer I., Lange E., Beer M. Characterization of a new chimeric marker vaccine candidate with a mutated antigenic E2-epitope. Vet. Microbiol. 2010, 142:45-50.
86. Ressang A.A. Studies on the pathogenesis of hog cholera, I. Demonstration of hog cholera virus subsequent to oral exposure. Zentralbl. Vet. B 1973, 20:256-271.
87. Rümenapf T., Stark R., Meyers G., Thiel H.-J. Structural proteins of hog cholera virus expressed by vaccinia virus: further characterization and induction of protective immunity. J. Virol. 1991, 65:589-597.
88. Sakoda Y., Wakamoto H., Tamura T., Nomura T., Naito M., Aoki H., Morita H., Kida H., Fukusho A. Development and evaluation of indirect enzyme-linked immunosorbent assay for a screening test to detect antibodies against classical swine fever virus. Jpn. J. Vet. Res. 2012, 60:85-94.
89. Sánchez O., Barrera M., Rodríguez M.P., Frías M.T., Figueroa N.E., Naranjo P., Montesino R., Farnos O., Castell S., Venereo A., Ganges L., Borroto C., Toledo J.R. Classical swine fever virus E2 glycoprotein antigen produced in adenovirally transduced PK-15 cells confers complete protection in pigs upon viral challenge. Vaccine 2008, 26:988-997.
90. Sasahara J., Kumagai T., Shimuzu Y., Furuuchi S. Field experiment of hog cholera vaccine prepared in guinea-pig kidney cell culture. Natl. Inst. Anim. Hlth. Quart. 1969, 9:83-91.
91. Schroeder S., von Rosen T., Blome S., Loeffen W., Haegeman A., Koenen F., Uttenthal Å. Evaluation of classical swine fever virus antibody detection assays with an emphasis on the differentiation of infected from vaccinated animals. Rev. Sci. Tech. Off. Int. Epiz. 2012, 31:997-1010.
92. Stegeman A., Elbers A., de Smit H., Moser H., Smak J., Pluimers F. The 1997-1998 epidemic of classical swine fever in the Netherlands. Vet. Microbiol. 2000, 73:183-196.
93. Summerfield A., Hofmann M.A., McCullough K.C. Low density blood granulocytic cells induced during classical swine fever are targets for virus infection. Vet. Immunol. Immunopathol. 1998, 63:289-301.
94. Summerfield A., Knoetig S.M., McCullough K.C. Lymphocyte apoptosis during classical swine fever: implication of activation-induced cell death. J. Virol. 1998, 72:1853-1861.
95. Summerfield A., Knoetig S.M., Tschudin R., McCullough K.C. Pathogenesis of granulocytopenia and bone marrow atrophy during classical swine fever involves apoptosis and necrosis of uninfected cells. Virology 2000, 272:50-60.
96. high+ T-cells before the onset of viraemia during classical swine fever. Vet. Immunol. Immunopathol. 2001, 78:3-19.
97. Summerfield A., Zingle K., Inumaru S., McCullough K.C. Induction of apoptosis in bone marrow neutrophil-lineage cells by classical swine fever virus. J. Gen. Virol. 2001, 82:1309-1318.
98. Sun Y., Li H.Y., Tian D.Y., Han Q.Y., Zhang X., Li N., Qiu H.J. A novel alphavirus replicon-vectored vaccine delivered by adenovirus induces sterile immunity against classical swine fever. Vaccine 2011, 29:8364-8372.
99. Suradhat S., Damrongwatanapokin S. The influence of maternal immunity on the efficacy of a classical swine fever vaccine against classical swine fever virus, genogroup 2.2, infection. Vet. Microbiol. 2003, 92:187-194.
100. Suradhat S., Damrongwatanapokin S., Thanawongnuwech R. Factors critical for successful vaccination against classical swine fever in endemic areas. Vet. Microbiol. 2007, 119:1-9.
101. Suradhat S., Intrakamhaeng M., Damrongwatanapokin S. The correlation of virus-specific interferon-gamma production and protection against classical swine fever virus infection. Vet. Immunol. Immunopathol. 2001, 83:177-189.
102. Suradhat S., Kesdangsakonwut S., Sada W., Buranapraditkun S., Wongsawang S., Thanawongnuwech R. Negative impact of porcine reproductive and respiratory syndrome virus infection on the efficacy of classical swine fever vaccine. Vaccine 2006, 24:2634-2642.
103. Suradhat S., Thanawongnuwech R. Upregulation of interleukin-10 gene expression in the leukocytes of pigs infected with porcine reproductive and respiratory syndrome virus. J. Gen. Virol. 2003, 84:2755-2760.
104. Suradhat S., Thanawongnuwech R., Poovorawan Y. Upregulation of IL-10 gene expression in porcine peripheral blood mononuclear cells by porcine reproductive and respiratory syndrome virus. J. Gen. Virol. 2003, 84:453-459.
105. Susa M., Konig M., Saalmuller A., Reddehase M.J., Thiel H.J. Pathogenesis of classical swine fever, B-lymphocyte deficiency caused by hog cholera virus. J. Virol. 1992, 66:1171-1175.
106. Tarradas J., Argilaguet J.M., Rosell R., Nofrarías M., Crisci E., Córdoba L., Pérez-Martín E., Díaz I., Rodríguez F., Domingo M., Montoya M., Ganges L. Interferon-gamma induction correlates with protection by DNA vaccine expressing E2 glycoprotein against classical swine fever virus infection in domestic pigs. Vet. Microbiol. 2010, 142:51-58.
107. Tarradas J., Monsó M., Muñoz M., Rosell R., Fraile L., Frías M.T., Domingo M., Andreu D., Sobrino F., Ganges L. Partial protection against classical swine fever virus elicited by dendrimeric vaccine-candidate peptides in domestic pigs. Vaccine 2011, 29:4422-4429.
108. Terpstra C., de Smit A.J. The 1997/1998 epizootic of swine fever in the Netherlands: control strategies under a non-vaccination regimen. Vet. Microbiol. 2000, 77:3-15.
109. Terpstra C., Wensvoort G. The protective value of vaccine-induced neutralizing antibody titres in swine fever. Vet. Microbiol. 1988, 16:123-128.
110. Terpstra C., Woortmeyer R., Barteling S.J. Development and properties of a cell culture produced vaccine for hog cholera based on the Chinese strain. Dtsch. Tierarztl. Wochenschr. 1990, 97:77-79.
111. Toledo J.R., Barrera M., Farnós O., Gómez S., Rodríguez M.P., Aguero F., Ormazabal V., Parra N.C., Suárez L., Sánchez O. Human αIFN co-formulated with milk derived E2-CSFV protein induce early full protection in vaccinated pigs. Vaccine 2010, 28:7907-7914.
112. Tu C., Lu Z., Le H., Yu X., Liu X., Li T., Zhang H., Yin Z. Phylogenetic comparison of classical swine fever virus in China. Virus Res. 2001, 81:29-37.
113. Uttenthal Å., Le Potier M.F., Romero L., de Mia G.M., Floegel-Niesmann G. Classical swine fever (CSF) marker vaccine-Trial I, Challenge studies in weaner pigs. Vet. Microbiol. 2001, 83:85-106.
114. van Oirschot J.T. Vaccinology of classical swine fever: from lab to field. Vet. Microbiol. 2003, 96:367-384.
115. van Rijn P.A. A common neutralizing epitope on envelope glycoprotein E2 of different pestiviruses: implications for improvement of vaccines and diagnostics for classical swine fever (CSF)?. Vet. Microbiol. 2007, 125:50-56.
116. van Rijn P.A., Miedema G.K.W., Wensvoort G., van Gennip H.G.P., Moormann R.J.M. Antigenic structure of envelope glycoprotein E1 of hog cholera virus. J. Virol. 1994, 68:3934-3942.
117. van Rijn P.A., van Gennip H.G.P., de Meijer E.J., Moormann R.J.M. A preliminary map of epitopes on envelope glycoprotein El of HCV strain Brescia. Vet. Microbiol. 1992, 33:221-230.
118. van Rijn P.A., van Gennip H.G.P., de Meijer E.J., Moormann R.J.M. Epitope mapping of envelope glycoprotein El of hog cholera virus strain Brescia. J. Gen. Virol. 1993, 74:2053-2060.
119. van Zijl M., Wensvoort G., de Kluyver E., Hulst M., Van der Gulden H., Gielkens A., Berns A., Moormann R. Live attenuated pseudorabies virus expressing envelope glycoprotein E1 of hog cholera virus protects swine against both pseudorabies and hog cholera. J. Virol. 1991, 65:2761-2765.
120. Weesendorp E., Stegeman A., Loeffen W. Dynamics of virus excretion via different routes in pigs experimentally infected with classical swine fever virus strains of high, moderate or low virulence. Vet. Microbiol. 2009, 133:9-22.
121. Weesendorp E., Stegeman A., Loeffen W. Quantification of classical swine fever virus in aerosols originating from pigs infected with strains of high, moderate or low virulence. Vet. Microbiol. 2009, 135:222-230.
122. Wehrle F., Renzullo S., Faust A., Beer M., Kaden V., Hofmann M.A. Chimeric pestiviruses: candidates for live-attenuated classical swine fever marker vaccines. J. Gen. Virol. 2007, 88:2247-2258.
123. Weiland E., Ahl R., Stark R., Weiland F., Thiel H.-J. A second envelope glycoprotein mediates neutralization of a pestivirus, hog cholera virus. J. Virol. 1992, 66:3677-3682.
124. Weiland E., Stark R., Haas B., Rümenapf T., Meyers G., Thiel H.-J. Pestivirus glycoprotein which induces neutralizing antibodies forms part of a disulfide-linked heterodimer. J. Virol. 1990, 64:3563-3569.
125. Wensvoort G. Topographical and functional mapping of epitopes on hog cholera virus with monoclonal antibodies. J. Gen. Virol. 1989, 70:2865-2876.
126. Wensvoort G., Boonstra J., Bodzinga B.G. Immunoaffinity purification and characterization of the envelope protein E1 of hog cholera virus. J. Gen. Virol. 1990, 71:531-540.
127. Wensvoort G., Terpstra C., Boonstra J., Bloemraad M., van Zaane D. Production of monoclonal antibodies against swine fever virus and their use in laboratory diagnosis. Vet. Microbiol. 1986, 12:101-108.
128. Wensvoort G., Terpstra C., de Kluijver E.P., Kragten C., Warnaar J.C. Antigenic differentiation of pestivirus strains with monoclonal antibodies against hog cholera virus. Vet. Microbiol. 1989, 21:9-20.
129. Yu M., Wang L.F., Shiell B.J., Morrissy C.J., Westbury H.A. Fine mapping of a C-terminal linear epitope highly conserved among the major envelope glycoprotein E2 (gp51 to gp54) of different pestiviruses. Virology 1996, 222:289-292.
130. rns using phage-displayed random peptide library. Arch. Virol. 2006, 151:37-54.
131. Zhu Y., Shi Z., Drew T.W., Wang Q., Qiu H., Guo H., Tu C. Antigenic differentiation of classical swine fever viruses in China by monoclonal antibodies. Virus Res. 2009, 142:169-174.